Global Diabetes Crisis: Over 800 Million Adults Affected, Many Untreated

A new study highlights a concerning rise in global diabetes, revealing that over 800 million adults now suffer from the condition, nearly doubling previous estimates. The research, published in The Lancet, underscores a startling reality: more than half of adults over 30 with diabetes aren’t receiving any form of treatment.

Key Findings and Rising Global Rates

In 2022, the global diabetic population included around 828 million adults aged 18 and older, encompassing both type 1 and type 2 diabetes. Among those over 30, approximately 445 million people—about 59%—are untreated, according to the study.

Previously, the World Health Organization (WHO) estimated around 422 million cases of diabetes worldwide. Diabetes is a metabolic condition characterized by elevated blood sugar levels, which, if left untreated, can lead to severe complications affecting the heart, blood vessels, nerves, and vital organs.

The research highlights a significant rise in diabetes rates since 1990, which have doubled from around 7% to 14%. Much of this surge is driven by increasing cases in low- and middle-income countries, where access to treatment remains limited.

Limited Access to Diabetes Treatment in Low-Income Countries

While some high-income nations have seen improvements in diabetes care, low-income regions continue to face severe challenges. In sub-Saharan Africa, for instance, only 5-10% of those with diabetes are receiving treatment. The study’s co-author, Professor Jean Claude Mbanya of the University of Yaounde I in Cameroon, emphasized that without access to insulin or other diabetes medications, many patients remain at serious risk of health complications.

“Untreated diabetes leaves millions at risk of serious health issues,” said Mbanya.

Study Insights: A First-of-Its-Kind Global Analysis

Conducted by the NCD Risk Factor Collaboration and WHO, this groundbreaking study is the first to provide a global analysis of diabetes rates and treatment accessibility across all countries. The findings are based on over 1,000 studies involving data from more than 140 million people worldwide.

To ensure accuracy, the study used both fasting plasma glucose levels and glycated hemoglobin measurements, common diagnostic criteria for diabetes. This dual approach helped avoid underestimations, particularly in regions like South Asia where single-method testing could miss cases.

The Growing Impact of Type 2 Diabetes

Although the study does not distinguish between type 1 and type 2 diabetes, previous research suggests that type 2 diabetes accounts for the majority of cases among adults. Type 2 diabetes is frequently associated with lifestyle factors such as obesity and poor diet, highlighting the need for preventive measures alongside treatment.

DiabetesCrisis #GlobalHealth #UntreatedDiabetes #HealthInequality #DiabetesAwareness #Type2Diabetes #PublicHealth #WHO #DiabetesTreatment #Healthcare